跳至主要内容
临床试验/JPRN-jRCTb020200036
JPRN-jRCTb020200036招募中2 期

Combination of hyaluronic acid and platelet-rich plasma injection therapy for knee osteoarthritis (double blinded randomized controlled trial) - HA and PRP injection for knee OA

Iio Kohei0 个研究点目标入组 90 人开始时间: 2020年12月25日最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 < 80age old(—)
性别
All

入选标准

  • 1) Prior written informed consent was obtained
  • 2) Diagnosed with knee osteoarthritis
  • 3) Age from 20 to 80
  • 4) Kellgren-Lawrence grade 2 or 3
  • 5) Possible to take MRI for exclusion of other diseases before treatment.
  • 6) Need unilateral knee treatment with visual analog scale (VAS) pain on severe knee more than 40 and that of the other less than 40
  • 7) Possible to visit hospital at all observational points ( considering Covid-19 pandemic, follow-up visit is substitutable for telephone consultiing )
  • 8) Good general condition

排除标准

  • 1) Coagulopathy (Platlet 150,000/micro litter)
  • 2) Anemia (Hb less than 9.0g/dl)
  • 3) Systemic infection
  • 4) Intake of anti-coagulant or anti-platelet drugs
  • 5) Intake of non-steroidal anti-inflammatory drugs within 2 weeks
  • 6) Taking hyaluronic acid injection into the target knee within 1 month
  • 7) Steroid treatment regardless of root of administration within 3 months
  • 8) PRP injection into the target knee within 1 year
  • 9) Past history of knee surgery within 1 year
  • 10) Those who are judged to be inappropreate by doctors who perform the regenerative medicine for any reason

研究者

发起方
Iio Kohei

相似试验